Letitia D Jones, M Anthony Moody, Amelia B Thompson. Clin Ther 2020
Times Cited: 10
Times Cited: 10
Times Cited
Times Co-cited
Similarity
Immune-correlates analysis of an HIV-1 vaccine efficacy trial.
Barton F Haynes, Peter B Gilbert, M Juliana McElrath, Susan Zolla-Pazner, Georgia D Tomaras, S Munir Alam, David T Evans, David C Montefiori, Chitraporn Karnasuta, Ruengpueng Sutthent,[...]. N Engl J Med 2012
Barton F Haynes, Peter B Gilbert, M Juliana McElrath, Susan Zolla-Pazner, Georgia D Tomaras, S Munir Alam, David T Evans, David C Montefiori, Chitraporn Karnasuta, Ruengpueng Sutthent,[...]. N Engl J Med 2012
40
Recent progress in broadly neutralizing antibodies to HIV.
Devin Sok, Dennis R Burton. Nat Immunol 2018
Devin Sok, Dennis R Burton. Nat Immunol 2018
30
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Fernando P Polack, Stephen J Thomas, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L Perez, Gonzalo Pérez Marc, Edson D Moreira, Cristiano Zerbini,[...]. N Engl J Med 2020
Fernando P Polack, Stephen J Thomas, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L Perez, Gonzalo Pérez Marc, Edson D Moreira, Cristiano Zerbini,[...]. N Engl J Med 2020
30
Neutralization tiers of HIV-1.
David C Montefiori, Mario Roederer, Lynn Morris, Michael S Seaman. Curr Opin HIV AIDS 2018
David C Montefiori, Mario Roederer, Lynn Morris, Michael S Seaman. Curr Opin HIV AIDS 2018
30
HIV-1 neutralizing antibodies: understanding nature's pathways.
John R Mascola, Barton F Haynes. Immunol Rev 2013
John R Mascola, Barton F Haynes. Immunol Rev 2013
30
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
Lawrence Corey, Peter B Gilbert, Michal Juraska, David C Montefiori, Lynn Morris, Shelly T Karuna, Srilatha Edupuganti, Nyaradzo M Mgodi, Allan C deCamp, Erika Rudnicki,[...]. N Engl J Med 2021
Lawrence Corey, Peter B Gilbert, Michal Juraska, David C Montefiori, Lynn Morris, Shelly T Karuna, Srilatha Edupuganti, Nyaradzo M Mgodi, Allan C deCamp, Erika Rudnicki,[...]. N Engl J Med 2021
30
Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities.
Yubin Liu, Wei Cao, Ming Sun, Taisheng Li. Emerg Microbes Infect 2020
Yubin Liu, Wei Cao, Ming Sun, Taisheng Li. Emerg Microbes Infect 2020
30
Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.
Xueling Wu, Zhi-Yong Yang, Yuxing Li, Carl-Magnus Hogerkorp, William R Schief, Michael S Seaman, Tongqing Zhou, Stephen D Schmidt, Lan Wu, Ling Xu,[...]. Science 2010
Xueling Wu, Zhi-Yong Yang, Yuxing Li, Carl-Magnus Hogerkorp, William R Schief, Michael S Seaman, Tongqing Zhou, Stephen D Schmidt, Lan Wu, Ling Xu,[...]. Science 2010
30
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody.
Rui Kong, Kai Xu, Tongqing Zhou, Priyamvada Acharya, Thomas Lemmin, Kevin Liu, Gabriel Ozorowski, Cinque Soto, Justin D Taft, Robert T Bailer,[...]. Science 2016
Rui Kong, Kai Xu, Tongqing Zhou, Priyamvada Acharya, Thomas Lemmin, Kevin Liu, Gabriel Ozorowski, Cinque Soto, Justin D Taft, Robert T Bailer,[...]. Science 2016
30
Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines.
Charlotte Pollard, Joanna Rejman, Winni De Haes, Bernard Verrier, Ellen Van Gulck, Thomas Naessens, Stefaan De Smedt, Pieter Bogaert, Johan Grooten, Guido Vanham,[...]. Mol Ther 2013
Charlotte Pollard, Joanna Rejman, Winni De Haes, Bernard Verrier, Ellen Van Gulck, Thomas Naessens, Stefaan De Smedt, Pieter Bogaert, Johan Grooten, Guido Vanham,[...]. Mol Ther 2013
20
A cationic nanoemulsion for the delivery of next-generation RNA vaccines.
Luis A Brito, Michelle Chan, Christine A Shaw, Armin Hekele, Thomas Carsillo, Mary Schaefer, Jacob Archer, Anja Seubert, Gillis R Otten, Clayton W Beard,[...]. Mol Ther 2014
Luis A Brito, Michelle Chan, Christine A Shaw, Armin Hekele, Thomas Carsillo, Mary Schaefer, Jacob Archer, Anja Seubert, Gillis R Otten, Clayton W Beard,[...]. Mol Ther 2014
20
Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Jeffrey M Jacobson, Jean-Pierre Routy, Seth Welles, Mark DeBenedette, Irina Tcherepanova, Jonathan B Angel, David M Asmuth, David K Stein, Jean-Guy Baril, Mehri McKellar,[...]. J Acquir Immune Defic Syndr 2016
Jeffrey M Jacobson, Jean-Pierre Routy, Seth Welles, Mark DeBenedette, Irina Tcherepanova, Jonathan B Angel, David M Asmuth, David K Stein, Jean-Guy Baril, Mehri McKellar,[...]. J Acquir Immune Defic Syndr 2016
20
A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption.
Sabine D Allard, Brenda De Keersmaecker, Anna L de Goede, Esther J Verschuren, Jeanette Koetsveld, Mariska L Reedijk, Carolien Wylock, Annelies V De Bel, Judith Vandeloo, Frank Pistoor,[...]. Clin Immunol 2012
Sabine D Allard, Brenda De Keersmaecker, Anna L de Goede, Esther J Verschuren, Jeanette Koetsveld, Mariska L Reedijk, Carolien Wylock, Annelies V De Bel, Judith Vandeloo, Frank Pistoor,[...]. Clin Immunol 2012
20
Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy.
Jean-Pierre Routy, Mohamed-Rachid Boulassel, Bader Yassine-Diab, Charles Nicolette, Don Healey, Renu Jain, Claire Landry, Oleg Yegorov, Irina Tcherepanova, Tamara Monesmith,[...]. Clin Immunol 2010
Jean-Pierre Routy, Mohamed-Rachid Boulassel, Bader Yassine-Diab, Charles Nicolette, Don Healey, Renu Jain, Claire Landry, Oleg Yegorov, Irina Tcherepanova, Tamara Monesmith,[...]. Clin Immunol 2010
20
Nonviral delivery of self-amplifying RNA vaccines.
Andrew J Geall, Ayush Verma, Gillis R Otten, Christine A Shaw, Armin Hekele, Kaustuv Banerjee, Yen Cu, Clayton W Beard, Luis A Brito, Thomas Krucker,[...]. Proc Natl Acad Sci U S A 2012
Andrew J Geall, Ayush Verma, Gillis R Otten, Christine A Shaw, Armin Hekele, Kaustuv Banerjee, Yen Cu, Clayton W Beard, Luis A Brito, Thomas Krucker,[...]. Proc Natl Acad Sci U S A 2012
20
Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial.
Rajesh T Gandhi, Douglas S Kwon, Eric A Macklin, Janet R Shopis, Anna P McLean, Nicole McBrine, Theresa Flynn, Lauren Peter, Amy Sbrolla, Daniel E Kaufmann,[...]. J Acquir Immune Defic Syndr 2016
Rajesh T Gandhi, Douglas S Kwon, Eric A Macklin, Janet R Shopis, Anna P McLean, Nicole McBrine, Theresa Flynn, Lauren Peter, Amy Sbrolla, Daniel E Kaufmann,[...]. J Acquir Immune Defic Syndr 2016
20
Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion.
Willy M Bogers, Herman Oostermeijer, Petra Mooij, Gerrit Koopman, Ernst J Verschoor, David Davis, Jeffrey B Ulmer, Luis A Brito, Yen Cu, Kaustuv Banerjee,[...]. J Infect Dis 2015
Willy M Bogers, Herman Oostermeijer, Petra Mooij, Gerrit Koopman, Ernst J Verschoor, David Davis, Jeffrey B Ulmer, Luis A Brito, Yen Cu, Kaustuv Banerjee,[...]. J Infect Dis 2015
20
mRNA vaccines - a new era in vaccinology.
Norbert Pardi, Michael J Hogan, Frederick W Porter, Drew Weissman. Nat Rev Drug Discov 2018
Norbert Pardi, Michael J Hogan, Frederick W Porter, Drew Weissman. Nat Rev Drug Discov 2018
20
A brief history of the global effort to develop a preventive HIV vaccine.
José Esparza. Vaccine 2013
José Esparza. Vaccine 2013
20
Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA.
Katalin Karikó, Hiromi Muramatsu, János Ludwig, Drew Weissman. Nucleic Acids Res 2011
Katalin Karikó, Hiromi Muramatsu, János Ludwig, Drew Weissman. Nucleic Acids Res 2011
20
Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in Situ.
Yen Cu, Kate E Broderick, Kaustuv Banerjee, Julie Hickman, Gillis Otten, Susan Barnett, Gleb Kichaev, Niranjan Y Sardesai, Jeffrey B Ulmer, Andrew Geall. Vaccines (Basel) 2013
Yen Cu, Kate E Broderick, Kaustuv Banerjee, Julie Hickman, Gillis Otten, Susan Barnett, Gleb Kichaev, Niranjan Y Sardesai, Jeffrey B Ulmer, Andrew Geall. Vaccines (Basel) 2013
20
Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.
Katalin Karikó, Hiromi Muramatsu, Frank A Welsh, János Ludwig, Hiroki Kato, Shizuo Akira, Drew Weissman. Mol Ther 2008
Katalin Karikó, Hiromi Muramatsu, Frank A Welsh, János Ludwig, Hiroki Kato, Shizuo Akira, Drew Weissman. Mol Ther 2008
20
Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo.
Kevin J Kauffman, Faryal F Mir, Siddharth Jhunjhunwala, James C Kaczmarek, Juan E Hurtado, Jung H Yang, Matthew J Webber, Piotr S Kowalski, Michael W Heartlein, Frank DeRosa,[...]. Biomaterials 2016
Kevin J Kauffman, Faryal F Mir, Siddharth Jhunjhunwala, James C Kaczmarek, Juan E Hurtado, Jung H Yang, Matthew J Webber, Piotr S Kowalski, Michael W Heartlein, Frank DeRosa,[...]. Biomaterials 2016
20
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure.
Peter D Kwong, John R Mascola. Immunity 2018
Peter D Kwong, John R Mascola. Immunity 2018
20
20
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge.
Norbert Pardi, Anthony J Secreto, Xiaochuan Shan, Fotini Debonera, Joshua Glover, Yanjie Yi, Hiromi Muramatsu, Houping Ni, Barbara L Mui, Ying K Tam,[...]. Nat Commun 2017
Norbert Pardi, Anthony J Secreto, Xiaochuan Shan, Fotini Debonera, Joshua Glover, Yanjie Yi, Hiromi Muramatsu, Houping Ni, Barbara L Mui, Ying K Tam,[...]. Nat Commun 2017
20
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.
Kizzmekia S Corbett, Barbara Flynn, Kathryn E Foulds, Joseph R Francica, Seyhan Boyoglu-Barnum, Anne P Werner, Britta Flach, Sarah O'Connell, Kevin W Bock, Mahnaz Minai,[...]. N Engl J Med 2020
Kizzmekia S Corbett, Barbara Flynn, Kathryn E Foulds, Joseph R Francica, Seyhan Boyoglu-Barnum, Anne P Werner, Britta Flach, Sarah O'Connell, Kevin W Bock, Mahnaz Minai,[...]. N Engl J Med 2020
20
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques.
Norbert Pardi, Celia C LaBranche, Guido Ferrari, Derek W Cain, István Tombácz, Robert J Parks, Hiromi Muramatsu, Barbara L Mui, Ying K Tam, Katalin Karikó,[...]. Mol Ther Nucleic Acids 2019
Norbert Pardi, Celia C LaBranche, Guido Ferrari, Derek W Cain, István Tombácz, Robert J Parks, Hiromi Muramatsu, Barbara L Mui, Ying K Tam, Katalin Karikó,[...]. Mol Ther Nucleic Acids 2019
20
Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix.
Wesley de Jong, Lorna Leal, Jozefien Buyze, Pieter Pannus, Alberto Guardo, Maria Salgado, Beatriz Mothe, Jose Molto, Sara Moron-Lopez, Cristina Gálvez,[...]. Vaccines (Basel) 2019
Wesley de Jong, Lorna Leal, Jozefien Buyze, Pieter Pannus, Alberto Guardo, Maria Salgado, Beatriz Mothe, Jose Molto, Sara Moron-Lopez, Cristina Gálvez,[...]. Vaccines (Basel) 2019
20
Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA.
Nathifa Moyo, Annette B Vogel, Søren Buus, Stephanie Erbar, Edmund G Wee, Ugur Sahin, Tomáš Hanke. Mol Ther Methods Clin Dev 2018
Nathifa Moyo, Annette B Vogel, Søren Buus, Stephanie Erbar, Edmund G Wee, Ugur Sahin, Tomáš Hanke. Mol Ther Methods Clin Dev 2018
20
Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV Infection.
Cynthia L Gay, Mark A DeBenedette, Irina Y Tcherepanova, Alicia Gamble, Whitney E Lewis, Anna B Cope, JoAnn D Kuruc, Kara S McGee, Mary F Kearney, John M Coffin,[...]. AIDS Res Hum Retroviruses 2018
Cynthia L Gay, Mark A DeBenedette, Irina Y Tcherepanova, Alicia Gamble, Whitney E Lewis, Anna B Cope, JoAnn D Kuruc, Kara S McGee, Mary F Kearney, John M Coffin,[...]. AIDS Res Hum Retroviruses 2018
20
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses.
Norbert Pardi, Michael J Hogan, Martin S Naradikian, Kaela Parkhouse, Derek W Cain, Letitia Jones, M Anthony Moody, Hans P Verkerke, Arpita Myles, Elinor Willis,[...]. J Exp Med 2018
Norbert Pardi, Michael J Hogan, Martin S Naradikian, Kaela Parkhouse, Derek W Cain, Letitia Jones, M Anthony Moody, Hans P Verkerke, Arpita Myles, Elinor Willis,[...]. J Exp Med 2018
20
A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.
Rogier W Sanders, Ronald Derking, Albert Cupo, Jean-Philippe Julien, Anila Yasmeen, Natalia de Val, Helen J Kim, Claudia Blattner, Alba Torrents de la Peña, Jacob Korzun,[...]. PLoS Pathog 2013
Rogier W Sanders, Ronald Derking, Albert Cupo, Jean-Philippe Julien, Anila Yasmeen, Natalia de Val, Helen J Kim, Claudia Blattner, Alba Torrents de la Peña, Jacob Korzun,[...]. PLoS Pathog 2013
20
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.
Susan P Buchbinder, Devan V Mehrotra, Ann Duerr, Daniel W Fitzgerald, Robin Mogg, David Li, Peter B Gilbert, Javier R Lama, Michael Marmor, Carlos Del Rio,[...]. Lancet 2008
Susan P Buchbinder, Devan V Mehrotra, Ann Duerr, Daniel W Fitzgerald, Robin Mogg, David Li, Peter B Gilbert, Javier R Lama, Michael Marmor, Carlos Del Rio,[...]. Lancet 2008
20
Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design.
Dennis R Burton, Lars Hangartner. Annu Rev Immunol 2016
Dennis R Burton, Lars Hangartner. Annu Rev Immunol 2016
20
Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1.
Marcella Sarzotti-Kelsoe, Robert T Bailer, Ellen Turk, Chen-li Lin, Miroslawa Bilska, Kelli M Greene, Hongmei Gao, Christopher A Todd, Daniel A Ozaki, Michael S Seaman,[...]. J Immunol Methods 2014
Marcella Sarzotti-Kelsoe, Robert T Bailer, Ellen Turk, Chen-li Lin, Miroslawa Bilska, Kelli M Greene, Hongmei Gao, Christopher A Todd, Daniel A Ozaki, Michael S Seaman,[...]. J Immunol Methods 2014
20
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.
Nicole A Doria-Rose, Chaim A Schramm, Jason Gorman, Penny L Moore, Jinal N Bhiman, Brandon J DeKosky, Michael J Ernandes, Ivelin S Georgiev, Helen J Kim, Marie Pancera,[...]. Nature 2014
Nicole A Doria-Rose, Chaim A Schramm, Jason Gorman, Penny L Moore, Jinal N Bhiman, Brandon J DeKosky, Michael J Ernandes, Ivelin S Georgiev, Helen J Kim, Marie Pancera,[...]. Nature 2014
20
Rapid evolution of the neutralizing antibody response to HIV type 1 infection.
Douglas D Richman, Terri Wrin, Susan J Little, Christos J Petropoulos. Proc Natl Acad Sci U S A 2003
Douglas D Richman, Terri Wrin, Susan J Little, Christos J Petropoulos. Proc Natl Acad Sci U S A 2003
20
Beyond antigens and adjuvants: formulating future vaccines.
Tyson J Moyer, Andrew C Zmolek, Darrell J Irvine. J Clin Invest 2016
Tyson J Moyer, Andrew C Zmolek, Darrell J Irvine. J Clin Invest 2016
20
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
Edward E Walsh, Robert W Frenck, Ann R Falsey, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Kathleen Neuzil, Mark J Mulligan, Ruth Bailey,[...]. N Engl J Med 2020
Edward E Walsh, Robert W Frenck, Ann R Falsey, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Kathleen Neuzil, Mark J Mulligan, Ruth Bailey,[...]. N Engl J Med 2020
20
Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies.
Michael S Seaman, Holly Janes, Natalie Hawkins, Lauren E Grandpre, Colleen Devoy, Ayush Giri, Rory T Coffey, Linda Harris, Blake Wood, Marcus G Daniels,[...]. J Virol 2010
Michael S Seaman, Holly Janes, Natalie Hawkins, Lauren E Grandpre, Colleen Devoy, Ayush Giri, Rory T Coffey, Linda Harris, Blake Wood, Marcus G Daniels,[...]. J Virol 2010
20
Lessons from the RV144 Thai phase III HIV-1 vaccine trial and the search for correlates of protection.
Jerome H Kim, Jean-Louis Excler, Nelson L Michael. Annu Rev Med 2015
Jerome H Kim, Jean-Louis Excler, Nelson L Michael. Annu Rev Med 2015
20
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults.
Glenda E Gray, Linda-Gail Bekker, Fatima Laher, Mookho Malahleha, Mary Allen, Zoe Moodie, Nicole Grunenberg, Yunda Huang, Doug Grove, Brittany Prigmore,[...]. N Engl J Med 2021
Glenda E Gray, Linda-Gail Bekker, Fatima Laher, Mookho Malahleha, Mary Allen, Zoe Moodie, Nicole Grunenberg, Yunda Huang, Doug Grove, Brittany Prigmore,[...]. N Engl J Med 2021
20
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Lindsey R Baden, Hana M El Sahly, Brandon Essink, Karen Kotloff, Sharon Frey, Rick Novak, David Diemert, Stephen A Spector, Nadine Rouphael, C Buddy Creech,[...]. N Engl J Med 2021
Lindsey R Baden, Hana M El Sahly, Brandon Essink, Karen Kotloff, Sharon Frey, Rick Novak, David Diemert, Stephen A Spector, Nadine Rouphael, C Buddy Creech,[...]. N Engl J Med 2021
20
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals.
Johannes F Scheid, Hugo Mouquet, Niklas Feldhahn, Michael S Seaman, Klara Velinzon, John Pietzsch, Rene G Ott, Robert M Anthony, Henry Zebroski, Arlene Hurley,[...]. Nature 2009
Johannes F Scheid, Hugo Mouquet, Niklas Feldhahn, Michael S Seaman, Klara Velinzon, John Pietzsch, Rene G Ott, Robert M Anthony, Henry Zebroski, Arlene Hurley,[...]. Nature 2009
20
Major Scientific Hurdles in HIV Vaccine Development: Historical Perspective and Future Directions.
Tiza Ng'uni, Caroline Chasara, Zaza M Ndhlovu. Front Immunol 2020
Tiza Ng'uni, Caroline Chasara, Zaza M Ndhlovu. Front Immunol 2020
20
Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding.
Johannes F Scheid, Hugo Mouquet, Beatrix Ueberheide, Ron Diskin, Florian Klein, Thiago Y K Oliveira, John Pietzsch, David Fenyo, Alexander Abadir, Klara Velinzon,[...]. Science 2011
Johannes F Scheid, Hugo Mouquet, Beatrix Ueberheide, Ron Diskin, Florian Klein, Thiago Y K Oliveira, John Pietzsch, David Fenyo, Alexander Abadir, Klara Velinzon,[...]. Science 2011
20
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection.
Rebecca M Lynch, Eli Boritz, Emily E Coates, Adam DeZure, Patrick Madden, Pamela Costner, Mary E Enama, Sarah Plummer, Lasonji Holman, Cynthia S Hendel,[...]. Sci Transl Med 2015
Rebecca M Lynch, Eli Boritz, Emily E Coates, Adam DeZure, Patrick Madden, Pamela Costner, Mary E Enama, Sarah Plummer, Lasonji Holman, Cynthia S Hendel,[...]. Sci Transl Med 2015
20
The complex challenges of HIV vaccine development require renewed and expanded global commitment.
Linda-Gail Bekker, Roger Tatoud, Francois Dabis, Mark Feinberg, Pontiano Kaleebu, Mary Marovich, Thumbi Ndung'u, Nina Russell, Jeremiah Johnson, Maureen Luba,[...]. Lancet 2020
Linda-Gail Bekker, Roger Tatoud, Francois Dabis, Mark Feinberg, Pontiano Kaleebu, Mary Marovich, Thumbi Ndung'u, Nina Russell, Jeremiah Johnson, Maureen Luba,[...]. Lancet 2020
20
20
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.